GSN gene frameshift mutations in Alzheimers disease
Conclusions
GSN frameshift mutations may be associated with AD. An increase in plasma GSN is probably a compensatory reaction in AD, which is a potential biomarker for early AD.
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Jiang, Y., Wan, M., Xiao, X., Lin, Z., Liu, X., Zhou, Y., Liao, X., Lin, J., Zhou, H., Zhou, L., Weng, L., Wang, J., Guo, J., Jiang, H., Zhang, Z., Xia, K., Li, J., Tang, B., Jiao, B., Shen, L. Tags: Open access Neurodegeneration Source Type: research
More News: Alzheimer's | Amyloidosis | Brain | Finland Health | Genetics | Neurology | Neurosurgery | Psychiatry | Study | Toxicology